During the past decade, Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" #1 sponsor was "Birte Glenthoj" with 4 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "University of Copenhagen" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Contura" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" #1 collaborator was "Glostrup University Hospital, Copenhagen" with 5 trials as a collaborator, "Rigshospitalet, Denmark" with 4 trials as a collaborator, "Copenhagen Hospital Corporation" with 3 trials as a collaborator, "The Danish Medical Research Council" with 3 trials as a collaborator and "University of Copenhagen" with 3 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" are "Schizophrenia" (5 trials), "Healthy Volunteers" (2 trials), "COVID" (1 trials), "Migraine With Aura" (1 trials) and "Migraine With or Without Aura" (1 trials). Many other conditions were trialed in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" in a lesser frequency.

Most popular intervention types in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" are "Drug" (10 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "risperidone" (2 trials), "Bulkamid" (1 trials), "Degarelix" (1 trials) and "Eletriptan 40 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup" are 7 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Neuropsychiatric Schizophrenia Research, University of Copenhagen, Psychiatric Center Glostrup, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".